Below are the most recent publications written about "Antibodies, Neutralizing" by people in Profiles.
-
Fong Y, Huang Y, Huang Y, Woo W, McGarry A, ??ez G, Dunkle LM, Cho I, Houchens CR, Martins K, Jayashankar L, Castellino F, Petropoulos CJ, Leith A, Haugaard D, Webb W, Lu Y, Yu C, Carpp LN, Randhawa AK, Andrasik MP, Kublin JG, Hutter J, Keshtkar-Jahromi M, Beresnev TH, Rodriguez CA, Tapia M, Turley CB, Zorrilla CD, Cohen SH, Kline SE, Barranco E, Corey L, Neuzil KM, Follmann D, Ake JA, Gay CL, Kotloff KL, Jones T, Koup RA, Donis RO, Gilbert PB. Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine. Clin Infect Dis. 2026 Apr 30; 82(4):e863-e874.
-
Ogundiran AI, Iftikhar S, Kumari N, Nekhai S, Chandran PL. Mannose residues in HIV-1 aggregation and its dispersion by mucin: Implications for neutralization. Biophys J. 2026 May 05; 125(9):2175-2194.
-
Heng F, Magaret CA, Rouphael NG, Branche AR, Fong Y, Carpp LN, Yu C, Chen S, Zhang B, Diemert DJ, Falsey AR, Graciaa DS, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, B?cker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Simon V, van Bakel H, Roberts PC, Gilbert PB. The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances. Vaccine. 2026 Mar 19; 76:128348.
-
Falc?o de Oliveira E, Carvalho AT, Venancio FA, Quili?o ME, Gabeira SCO, Leite SHDS, Sal? MDS, Lima SMB, Alves NDS, Moura LDC, Schwarcz WD, Azevedo AS, Demarchi LHF, Zardin MCSU, Lichs GGC, Taira DL, Nascimento AID, Fernandes WS, Alves NO, Casaril Arrua AE, Medeiros MJ, Cunha RVD, Vasconcelos Z, Santos-Pinto CDB, Nielsen-Saines K. Zika virus infection in early pregnancy increases the likelihood of persistent neutralizing antibodies. PLoS Negl Trop Dis. 2026 Jan; 20(1):e0013906.
-
Stromberg ZR, Silva EE, Johnston SC, Johnson DM, Hall D, Adjei EF, Altin JA, Abisoye-Ogunniyan A, Gollott T, He W, Jones IKA, Kwilas S, Lund SJ, Mead HL, Nelson GA, Ouyang L, Peters SKG, Schwedler JL, Trecazzi CZ, Turner MW, Ye C, Bradfute SB, Fischer NO, Hooper JW, Ladner JT, Rasley A, Negrete OA. An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse models. Front Immunol. 2025; 16:1682418.
-
Tuchynskaya K, Vorovitch M, Kruglov Y, Mostipanova G, Kholodilov I, Ivanova A, Kuchina V, Rogova A, Karganova G. Mono-WNV and combined WNV/TBEV inactivated vaccine efficacy against a wide range of WNV and TBEV strains. Front Immunol. 2025; 16:1715371.
-
Tsai WY, Pierson TC, Wrammert J, Dejnirattisai W, Jumnainsong A, Mongkolsapaya J, Screaton G, Crowe JE, Wang WK. Mature dengue virus particles inactivated by a non-ionic detergent retain quaternary neutralizing epitopes and induce potent neutralizing antibodies. Front Immunol. 2025; 16:1626823.
-
Oliveira EF, Santos-Pinto CDB, Venancio FA, Quili?o ME, Gabeira SCO, Carvalho AT, Leite SHDS, Lima SMB, Alves NDS, Moura LDC, Schwarcz WD, Azevedo AS, Demarchi LHF, Zardin MCSU, Lichs GGC, Taira DL, Souza Fernandes W, Alves NO, Arrua AEC, Nascimento AID, Mareto LK, Azevedo MV, Maciel CG, Medeiros MJ, Vasconcelos Z, Cunha RVD, Nielsen-Saines K. Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure. Int J Epidemiol. 2025 Aug 18; 54(5).
-
Slotkin R, Kyriakides TC, Yu V, Chen X, Kundu A, Gupta S. CoVimmune COVID-19 Immunity Calculator: Web Application Development and Validation Study. JMIR Form Res. 2025 Apr 22; 9:e59467.
-
Lopes da Silva VG, Schmitz GJH, Sullivan KE, Barbate J, de Haro Azinar MI, Aranda CS, de Moraes-Pinto MI. Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls. Front Immunol. 2025; 16:1538453.